Pennsylvania Advances Bill to Boost Independent Cannabis Firms

December 14, 2023 · Green Market Report

This week, Pennsylvania’s legislature passed a bill to allow more cultivators and independent dispensaries to grow and sell directly to consumers in the state.

Senate Bill 773, which is now awaiting Gov. Josh Shapiro’s signature, was passed by the state Senate and then altered in the House. It was at one point expected to address broader issues, such as home growing or full adult-use legalization, but the end version was more limited.

Instead, it focused on allowing all 25 independent medical cannabis growers and dispensaries in the state more freedom to conduct direct sales and to produce their own products.

It’s a big shift, as currently, Pennsylvania law limits how many growers can also be retailers to five. That created somewhat of a concentrated oligarchy in the state market, with most growers having to sell to a few large retailers.

One of the key changes made in the House was the reduction in the number of dispensary permits available to independent growers/processors. The Senate version allowed for two, while the House cut that to just one, a move that frustrated some, including the bill’s author.

“That’s certainly frustrating to us because we did a lot of market research and calculations in terms of what we determined should be two permits versus one,” Sen. Chris Gebhard, a Republican from Lebanon County told Penn Live, adding that lawmakers put prospective grower and retailers “in a very difficult position long term to compete in the marketplace.”

Despite the reduction in permits, the Senate agreed to the House version.

“Half a loaf is better than no loaf at all,” said Senate Minority Leader Jay Costa, a Democrat from Allegheny County.

Changes made in the House also include provisions that permit stand-alone dispensaries to seek licenses to grow cannabis as well.

SB 773 also introduces a temporary moratorium on the transfer of licenses by grower/processors and dispensaries, specifically designed to shield independent growers and retailers from being taken over by larger conglomerates. Large, vertically integrated companies have previously dominated the landscape, overshadowing smaller independent entities.

The economic impact could be substantial. Pennsylvania’s medical market has experienced robust growth, with monthly sales figures reaching between $115 million and $140 million. According to Penn Live, the state also collected $37.5 million last fiscal year from a 5% tax on wholesale cannabis sales. (Full Story)

Next Post

New York’s Grower Showcase Events Provide Pipeline for Producers, Refreshing Space for Buyers

New York’s rollout of legal weed shops has been a mess, to say the least. Designed to revolutionize the legal weed marketplace, New York has instead fallen short either by design or outside factors, including numerous lawsuits.  One of the…
Read
Previous Post

How to Tell if Your Cannabis Plant Is Male or Female

Cannabis cultivators the world over know the obsessive, purgatorial feeling of waiting for their plants to mature to discern sex—female, male or hermaphrodite. A male plant, while essential for reproduction, can also run rampant across a garden and devastate an…
Read
Random Post

Kansas gov won’t use executive powers to legalize medical marijuana

Kansas Gov. Laura Kelly said this week that she will not use her office’s executive powers to legalize medical marijuana or to decriminalize cannabis possession. A vocal advocate of marijuana reform who nonetheless says she opposes adult-use legalization, Kelly has said she would sign a…
Read
Random Post

States That Legalize Marijuana See ‘Significantly’ Lower Rate Of Cannabis Use Disorder Cases At ERs Compared To Non-Legal States, Study Finds

The odds that a patient visiting the emergency department is diagnosed with cannabis use disorder (CUD) is nearly 50 percent lower in states that have legalized marijuana compared to non-legal states, according to a new study. And researchers say the…
Read
Random Post

MindMed Says it is Fully Funded Through 2025

Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (NEO: MMED) reported its financial results for the second quarter ending on June 30. The company has no revenue to report at this time, but the net loss for the quarter increased to $29.1 million versus last…
Read
Random Post

Critics question whether Biden-signed marijuana research law has ‘any value’

Starved for good news from Washington DC, the broad cannabis movement greeted President Joe Biden’s signing of the Medical Marijuana and Cannabidiol Research Expansion Act into law in December with enthusiasm and hope. Surely, new research supporting the rescheduling of marijuana –…
Read